[Treatment of hepatic encephalopathy after portal shunt in the patient with cirrhosis].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003106:Colon / Q000601:surgery; D004044:Dietary Proteins / Q000008:administration & dosage; D006501:Hepatic Encephalopathy / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007792:Lactulose / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000150:complications*; D009584:Nitrogen / Q000378:metabolism; D011167:Portacaval Shunt, Surgical; D011169:Portal Vein / Q000601:surgery
D000900:Anti-Bacterial Agents; D004044:Dietary Proteins; D007792:Lactulose; D009584:Nitrogen
Traitement de l'encéphalopathie hépatique après dérivation portale chez le cirrhotique